Mohan Bala - Net Worth and Insider Trading
Mohan Bala Net Worth
The estimated net worth of Mohan Bala is at least $84,972 dollars as of 2026-08-11. Mohan Bala is the SVP, Chief Development Officer of Mersana Therapeutics Inc and owns about 2,922 shares of Mersana Therapeutics Inc (MRSN) stock worth over $84,972. Details can be seen in Mohan Bala's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mohan Bala has not made any transactions after 2025-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mohan Bala
Mohan Bala Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mohan Bala owns 1 companies in total, including Mersana Therapeutics Inc (MRSN) .
Click here to see the complete history of Mohan Bala’s form 4 insider trades.
Insider Ownership Summary of Mohan Bala
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| MRSN | Mersana Therapeutics Inc | 2025-10-27 | SVP & Chief Development Officer |
Mohan Bala Latest Holdings Summary
Mohan Bala currently owns a total of 1 stock. Mohan Bala owns 2,922 shares of Mersana Therapeutics Inc (MRSN) as of October 27, 2025, with a value of $84,972.
Latest Holdings of Mohan Bala
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRSN | Mersana Therapeutics Inc | 2025-10-27 | 2,922 | 29.08 | 84,972 |
Holding Weightings of Mohan Bala
Mohan Bala Form 4 Trading Tracker
According to the SEC Form 4 filings, Mohan Bala has made a total of 7 transactions in Mersana Therapeutics Inc (MRSN) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Mersana Therapeutics Inc is the sale of 77 shares on October 27, 2025, which brought Mohan Bala around $762.
Insider Trading History of Mohan Bala
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Mohan Bala Trading Performance
Mohan Bala Ownership Network
Ownership Network List of Mohan Bala
Ownership Network Relation of Mohan Bala
Mohan Bala Owned Company Details
What does Mersana Therapeutics Inc do?
Who are the key executives at Mersana Therapeutics Inc?
Mohan Bala is the SVP & Chief Development Officer of Mersana Therapeutics Inc. Other key executives at Mersana Therapeutics Inc include Sr. VP & Finance & Product stgy Brian Deschuytner , VP & Controller Ashish Mandelia , and Chief Scientific Officer Timothy B Lowinger .
Mersana Therapeutics Inc (MRSN) Insider Trades Summary
Over the past 18 months, Mohan Bala made 1 insider transaction in Mersana Therapeutics Inc (MRSN) with a net sale of 77. Other recent insider transactions involving Mersana Therapeutics Inc (MRSN) include a net sale of 2,012 shares made by Huber Martin H. Jr. ,
In summary, during the past 3 months, insiders sold 0 shares of Mersana Therapeutics Inc (MRSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,089 shares of Mersana Therapeutics Inc (MRSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,089 shares.
Mersana Therapeutics Inc (MRSN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mersana Therapeutics Inc Insider Transactions
Mohan Bala Mailing Address
Above is the net worth, insider trading, and ownership report for Mohan Bala. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mohan Bala's mailing address is: Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
